Milestone updates - revised 13 count

below includes AMBS Capital Markets blog 08/10/14

http://www.thechairmansblog.com/amarantus-bio...-strategy/

01.) LymPro - LP-002 data (est. Sept.)
02.) Lympro - JV Partner (est. 4Q14)
03.) Eltoprazine - signif. announcements, incl. 200 patient Ph. 2b trial (est. 4Q14)
04.) MANF - Ophthalmological ear toxicology complete data sets (est. 4Q14)
05.) MANF RP - functional data & addit. efficacy data sets (est. 4Q14)
06.) MANF / GDNF - Renishaw Ph. 2B test trial results (est. 4Q14)

07.) potential - MANF RP orphan (est. Sept.)
08.) potential - MANF DB-1 Wolframs orphan (est. 4Q14)

09.) potential - financial engineering (est. 9/22 ASM)
10.) potential - grant funding
11.) potential - new acquisition / Cerora AD scanner / big bd. company
12.) potential - active PhenoGuard JV Partnership update
13.) potential - Diagnostics Div. spin out

......please feel free to copy, paste & add to in you next post

these entries are the best of what I can culminate - but accuracy can vary accordingly...

All the Best, JP